Patents by Inventor R. Saul Levinson
R. Saul Levinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6899890Abstract: The present invention relates to a novel essentially pH neutral vaginal drug delivery system suitable for modified delivery of a therapeutically active material in the vaginal cavity. The vaginal drug delivery system comprises an essentially pH neutral emulsion having globules having two phases, an internal water soluble phase and an external water-insoluble phase or film, wherein the water-soluble interior phase contains a therapeutically active drug or drugs. One novel aspect of the vaginal drug delivery system is that the internal water soluble phase comprises an acidic buffered phase.Type: GrantFiled: March 20, 2002Date of Patent: May 31, 2005Assignee: KV Pharmaceutical CompanyInventors: Mitchell I. Kirschner, R. Saul Levinson, Thomas C. Riley, Marc S. Hermelin
-
Publication number: 20040101554Abstract: This invention relates to novel dosage formulations for nutritional compositions comprising fatty acids derived from both plant and animal sources and methods for minimizing unpleasant taste, regurgitation, gastroesophageal reflux, dyspepsia, nausea, or difficulty in swallowing or ingesting nutritional agents. The nutritional compositions are intended for use by pregnant or lactating women.Type: ApplicationFiled: November 14, 2003Publication date: May 27, 2004Applicant: DrugTech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, Marc S. Hermelin
-
Patent number: 6696083Abstract: The efficacy of vitamins and other nutritional agents in treating and preventing various disease states is improved by administering therapeutically effective levels of these agents on a substantially continuous, 24-hour basis. The concentration of lipid peroxides formed by the autoxidation of lipids, and the concentration of oxygen free radicals, are reduced by continuously administering antioxidant agents. The regeneration of nerve tissue is improved by continuously administering at least one pharmaceutically-acceptable B complex vitamin.Type: GrantFiled: January 30, 1998Date of Patent: February 24, 2004Assignee: DrugTech CorporationInventors: George N. Paradissis, R. Saul Levinson, Mitchell I. Kirschner, Marc S. Hermelin
-
Publication number: 20030216351Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: ApplicationFiled: June 10, 2003Publication date: November 20, 2003Applicant: DrugTech CorporationInventors: Marc S. Hermelin, R. Saul Levinson, Geroge Paradissis
-
Publication number: 20030180348Abstract: This invention relates to a novel transcellular drug delivery system suitable for controlled delivery of a therapeutically active material across various membranes. The transcellular drug delivery system has a bioadhesive unilamellar vesicle defining an amphiphilic exterior and an aqueous interior, wherein a therapeutically active ingredient is contained inside the aqueous interior.Type: ApplicationFiled: March 22, 2002Publication date: September 25, 2003Inventors: R. Saul Levinson, Thomas C. Riley
-
Publication number: 20030180366Abstract: The present invention relates to a novel essentially pH neutral vaginal drug delivery system suitable for modified delivery of a therapeutically active material in the vaginal cavity. The vaginal drug delivery system comprises an essentially pH neutral emulsion having globules having two phases, an internal water soluble phase and an external water-insoluble phase or film, wherein the water-soluble interior phase contains a therapeutically active drug or drugs. One novel aspect of the vaginal drug delivery system is that the internal water soluble phase comprises an acidic buffered phase.Type: ApplicationFiled: March 20, 2002Publication date: September 25, 2003Inventors: Mitchell I. Kirschner, R. Saul Levinson, Thomas C. Riley, Marc S. Hermelin
-
Patent number: 6576666Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: GrantFiled: June 21, 2001Date of Patent: June 10, 2003Assignee: Drugtech CorporationInventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
-
Patent number: 6569857Abstract: The present disclosure relates to novel nutritional compositions and methods for augmenting the possibility of conception while increasing nutritional stores to aid development of healthy embryos and child growth. The nutritional compositions are intended for use by both males and females planning to conceive a child.Type: GrantFiled: May 3, 1999Date of Patent: May 27, 2003Assignee: Drugtech CorporationInventors: Marc S. Hermelin, R. Saul Levinson
-
Publication number: 20030068372Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.Type: ApplicationFiled: December 3, 2002Publication date: April 10, 2003Applicant: Drugtech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
-
Publication number: 20030021842Abstract: The present invention relates to a means for creating a mass having structural integrity, including a rapidly disintegratable tablet for administration with or without the use of water. The present invention has a wide variety of different uses and applications. One embodiment is a tablet intended for oral administration. The tablet comprises at least one active ingredient and a mixture of excipients. The excipients provide desired characteristics and physical properties and when the tablet is sintered or heated, excellent tablet binding characteristics are obtained. The tablet is intended primarily for oral administration and dissolves in the presence of water. Also disclosed is a process for the preparation of a rapidly disintegratable tablet for administration with or without the use of water.Type: ApplicationFiled: September 18, 2002Publication date: January 30, 2003Applicant: DRUGTECH CORPORATIONInventors: Yury Lagoviyer, R. Saul Levinson, Denis Stotler, Thomas C. Riley
-
Publication number: 20020187205Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.Type: ApplicationFiled: July 31, 2002Publication date: December 12, 2002Applicant: K-V Pharmaceutical CompanyInventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
-
Patent number: 6488956Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.Type: GrantFiled: November 24, 1999Date of Patent: December 3, 2002Assignee: Drugtech CorporationInventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
-
Publication number: 20020173510Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: April 25, 2002Publication date: November 21, 2002Applicant: DrugTech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Patent number: 6479545Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: GrantFiled: September 30, 1999Date of Patent: November 12, 2002Assignee: Drugtech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Patent number: 6465010Abstract: The present invention relates to a means for creating a mass having structural integrity, including a rapidly disintegratable tablet for administration with or without the use of water. The present invention has a wide variety of different uses and applications. One embodiment is a tablet intended for oral administration. The tablet comprises at least one active ingredient and a mixture of excipients. The excipients provide desired characteristics and physical properties and when the tablet is sintered or heated, excellent tablet binding characteristics are obtained. The tablet is intended primarily for oral administration and dissolves in the presence of water. Also disclosed is a process for the preparation of a rapidly disintegratable tablet for administration with or without the use of water.Type: GrantFiled: July 12, 2001Date of Patent: October 15, 2002Assignee: Drugtech CorporationInventors: Yury Lagoviyer, R. Saul Levinson, Denis Stotler, Thomas C. Riley
-
Publication number: 20020137749Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: March 27, 2002Publication date: September 26, 2002Applicant: DrugTech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Publication number: 20020044961Abstract: This invention relates to novel dosage formulations for nutritional compositions comprising fatty acids derived from both plant and animal sources and methods for minimizing unpleasant taste, regurgitation, gastroesophageal reflux, dyspepsia, nausea, or difficulty in swallowing or ingesting nutritional agents. The nutritional compositions are intended for use by pregnant or lactating women.Type: ApplicationFiled: October 9, 2001Publication date: April 18, 2002Applicant: DrugTech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, Marc S. Hermelin
-
Publication number: 20020032234Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: ApplicationFiled: June 21, 2001Publication date: March 14, 2002Applicant: DRUGTECH CORPORATIONInventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
-
Patent number: 6352713Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.Type: GrantFiled: December 1, 1999Date of Patent: March 5, 2002Assignee: Drugtech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
-
Patent number: 6284270Abstract: The present invention relates to a means for creating a mass having structural integrity, including a rapidly disintegratable tablet for administration with or without the use of water. The present invention has a wide variety of different uses and applications. One embodiment is a tablet intended for oral administration. The tablet comprises at least one active ingredient and a mixture of excipients. The excipients provide desired characteristics and physical properties and when the tablet is sintered or heated, excellent tablet binding characteristics are obtained. The tablet is intended primarily for oral administration and dissolves in the presence of water. Also disclosed is a process for the preparation of a rapidly disintegratable tablet for administration with or without the use of water.Type: GrantFiled: August 4, 1999Date of Patent: September 4, 2001Assignee: Drugtech CorporationInventors: Yury Lagoviyer, R. Saul Levinson, Denis Stotler, Thomas C. Riley